Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2015 01:00 ET | Source: Addex Therapeutics

Addex Therapeutics Reports 2014 Financial Results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} 2014 Financial Highlights Increased...
March 09, 2015 02:00 ET | Source: Addex Therapeutics

Addex Raises CHF2.8 million in a Private Placement and Extends Cash Runway Through 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 9 March 2015 -...
February 23, 2015 01:00 ET | Source: Addex Therapeutics

Addex Initiates Dipraglurant Receptor Occupancy Clinical Study in Collaboration with Johns Hopkins University with Funding from The Michael J. Fox Foundation

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 23 February 2015...
February 19, 2015 01:00 ET | Source: Addex Therapeutics

Addex mGluR2 NAM Demonstrates Protection in Preclinical Model of Ischemic Neuronal Death

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 19 February 2015...
January 19, 2015 01:00 ET | Source: Addex Therapeutics

Addex and Dystonia Medical Research Foundation Announce Partnership to Explore the Therapeutic use of Dipraglurant in the Treatment of Dystonia

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland /Chicago, USA, 19...
January 09, 2015 01:00 ET | Source: Addex Therapeutics

Addex Completes 2014 with Strong Cash Position and Provides 2015 Strategic Update

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 9 January 2015 -...
January 07, 2015 01:00 ET | Source: Addex Therapeutics

Addex and NIAAA Enter Collaboration to Evaluate ADX71441 in Alcohol Use Disorder

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ...
December 17, 2014 01:00 ET | Source: Addex Therapeutics

Addex Amends mGlu2PAM Collaboration Agreement and Receives USD757,000

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 17 December 2014...
October 21, 2014 01:00 ET | Source: Addex Therapeutics

Addex and the Charcot-Marie-Tooth Association enter collaboration to advance ADX71441 in Charcot-Marie-Tooth 1A disorder

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 21 October 2014 -...
September 30, 2014 01:00 ET | Source: Addex Therapeutics

Addex Therapeutics Reports First Half 2014 Financial Results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} ...